Earlier this week, an FDA advisory committee recommended that the agency withdraw Amag Pharmaceutical’s preterm birth drug Makena, a treatment that brought in more than $1 billion in sales before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results